Characterizing Rho Kinase Activity Using a Novel PET Tracer in Hypertrophied Cardiomyocytes

• Main Author: Moreau, Steven
• Other Authors: Fernando, Pasan
• Language: en
• Published: Université d'Ottawa / University of Ottawa 2012
• Subjects: cardiac hypertrophy; rho kinase; positron emission tomography; N-[11C]-methyl-hydroxyfasudil
• Online Access: http://hdl.handle.net/10393/22887; http://dx.doi.org/10.20381/ruor-5810

Cardiac hypertrophy is a compensatory response to increased work load or stress on the heart, but over time can lead to heart failure and death. The molecular mechanisms underlying this disease are still not completely understood, however the Rho/Rho kinase pathway has been shown to play a role. N-[11C]-methyl-hydroxyfasudil, a PET radiotracer, binds to active Rho kinase and could be a possible tracer for hypertrophy. Hypertrophy was induced in vitro using the β-adrenergic receptor agonist isoproterenol to evaluate optimal Rho kinase activity. Rho kinase activity data was correlated to N-[11C]-methyl-hydroxyfasudil binding. Cardiac hypertrophy was verified with an increase in nuclear size (1.74 fold) and cell size (~2 fold), activation of hypertrophic signalling pathways, and increased Rho kinase activity (1.64 fold). This correlated to a 10.3% increase in N-[11C]-methyl-hydroxyfasudil binding. This data suggests that N-[11C]-methyl-hydroxyfasudil may be useful as a radiotracer for detecting cardiac hypertrophy and merits further in vivo investigation.